By Karen Peattie
Dxcover has appointed diagnostics industry professional Dr David Eustace as operations director to drive product development, manufacturing, regulatory and laboratory operations.
The appointment comes following a period of substantial growth for the Strathclyde University spinout, which is developing blood tests for early detection of cancer.
Dr Eustace joins the team from Bruker Daltonics, the American-owned scientific instruments and diagnostics company, where he worked as operations director in Germany and Scotland.
He has more than 13 years’ experience in the industry, working for Renishaw Diagnostics and Bruker Molecular Testing, most recently on its Covid-19 response projects at its plant in Germany.
Earlier this year, Dxcover completed its second clinical study, showcasing the clinical utility of its brain cancer test, and recently moved into new lab and office space in Glasgow’s Innovation District in preparation for further growth.
Its liquid biopsy technology is fast, inexpensive, and only requires a blood sample to be taken and sent to the lab for analysis with infra-red light. Dxcover’s “drop, dry, detect” technology provides results in minutes and is powered by artificial intelligence to detect the signs of cancer.
Dr Eustace said: “The Covid-19 pandemic has heightened the need for quicker and more effective diagnostic tests to help healthcare professionals triage patients effectively and make sure that the best possible care is delivered as quickly as possible.
“Earlier cancer diagnoses result in significantly higher survival rates and the Dxcover team has been making huge steps to translate groundbreaking technology into the clinic to make that possible”.
Dxcover aims to be a world leader in liquid biopsy and artificial intelligence for early detection of cancer and other diseases. Since its spinout in 2019, the company has raised £5.1 million in funding to progress its multi-cancer development programme.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here